SEBI Reg. Investment Advisor

Download App

Help Center Pricing

Recent:

Wockhardt to sell entire nutrition biz to Abbott

Wockhardt Ltd. | Pharmaceuticals & Drugs | Healthcare | BSE: 532300 | NSE: WOCKPHARMA

29 Jul 2009 Evaluate

Wockhardt Ltd, which recently undertook a debt restructuring scheme, has signed an agreement to divest its non-core nutritional business to Abbott, a global healthcare company. Sources said the deal was worth close to $130 million (Rs 625 crore). The company said the transaction was subject to customary closing conditions and various approvals, and would be closed in the second half of 2009.

The company’s nutrition business includes some of the major child care brands, such as Farex, Dexolac and Nusobee infant formulas, and Farex weaning cereal. The adult protein supplement, Protinex, is a segment leader in the vitamin and health supplement category.

Wockhardt had acquired Dumex India, along with its two products, Protinex and Farex, from Royal Numico NV of The Netherlands for an undisclosed amount in 2006. At that time, Protinex and Farex, both well-known nutrition brands in the country for over 50 years, had a combined annual sales of Rs 60 crore.

Wockhardt’s over Rs 3,400 crore debt was restructured by its lenders in June. As per the corporate debt restructuring (CDR) scheme, it has to divest its non-core assets at an estimated value of Rs 790 crore, within the next six years. It had already mobilised close to Rs 300 crore from the recent sale of its loss-making German subsidiary, Esparma, to Mova GmbH and the animal health division to Vétoquinol, a French veterinary care company.

The company is also looking at divesting a 32-acre dairy and milk processing unit in Punjab which the company inherited from its acquisition of Dumex India and part of 250 acres in Aurngabad. It was also planning to divest less than 26 per cent stake in Wockhardt Hospitals, which has 12 hospitals, for a valuation of Rs 800-1,200 crore. But the company may wait for more time to get good valuations.

crack crack

Wockhardt Share Price

1401.80 5.00 (0.36%)

20-Apr-2026 14:27 View Price Chart

Peers

Company Name	CMP
Sun Pharma Inds.	1669.70
Dr. Reddys Lab	1235.90
Cipla	1232.85
Zydus Lifesciences	937.40
Lupin	2329.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

PROPRIETARY FRAMEWORK

Portfolio
Architecture >
Stock Picking.

Stop managing a collection of "tips." Access the ABC Framework to build a portfolio that survives cycles and compounds wealth.

Core for Stability

Booster for Alpha

Amplifier for Exponential Wealth

Build a Stress-Tested Portfolio.

Our Sapphire Advisory uses the ABC Concept to ensure you never have to panic during a market correction.

Core Stocks

STABILITY

Booster Stocks

GROWTH

Amplifier Stocks

ASYMMETRY

● Conflict-Free ● SEBI Registered ● 15Y+ Track Record

Access Sapphire ABC Strategy →

Limited Capacity for New Fiduciary Partners

Wockhardt to sell entire nutrition biz to Abbott

MoneyWorks4Me Premium

Follow us at

MoneyWorks4Me

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.